China Pharma (NYSE:CPHI) Now Covered by StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research report issued on Tuesday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Performance

Shares of CPHI opened at $0.19 on Tuesday. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.69. The firm’s fifty day moving average is $0.21 and its two-hundred day moving average is $0.22. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.